4D Molecular Therapeutics revenue was $14.13 m in FY, 2018 which is a (144.0%) year over year increase from the previous period.
4D Molecular Therapeutics revenue breakdown by business segment: 63.6% from Collaboration and Research Revenue (Related Parties) and 36.4% from Collaboration and Research Revenue
|FY, 2018||FY, 2017|
|Collaboration and Research Revenue (Related Parties)||$8.99 m||$2.61 m|
|Collaboration and Research Revenue||$5.14 m||$3.18 m|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.